Future clinical trials comparing antiarrhythmic drugs and implantable cardioverter-defibrillators face ethical challenges due to device efficacy. High-quality data from implantable cardioverter-defibrillators now enable drug efficacy studies without direct patient comparison.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: